Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
6.120 / 17.033
#48954

Re: Farmas USA

Gracias Amigo!!!!

Ahora a esperar a AMRN!!!!!

;-))

#48958

Re: Farmas USA

tkmr locura

#48959

Re: Farmas USA

Funding Announced

Most of the recent attention surrounding Ebola drugs has focused upon Tekmira Pharmaceuticals (NASDAQ:TKMR), a small Canadian biotech outfit which has been working with US defense agencies to develop an effective drug. While Tekmira was obviously in the driver's seat, we like to look for other names which can benefit from investor speculation and our focus was on BioCryst Pharmaceuticals (NASDAQ:BCRX) as a trading vehicle. While BioCryst shares have underperformed those of Tekmira, we could see that gap close moving forward as the company announced the National Institute of Allergy & Infectious Diseases, or NIAID, will fund up to $4.1 million to assist in the advancement of BioCryst's BCX4430 (the treatment which has thus far shown promising results in fighting Hemorrhagic Fever Virus Diseases).

Te puede interesar...
  1. Primeras dudas sobre la 'Trumponomics', ¿corrección o toma de beneficios?
  2. Nvidia bate expectativas pero decepciona. Insiders reafirman su posición